论文部分内容阅读
目的 探讨综合疗法在急性病毒性脑炎治疗中的临床价值。方法 设治疗组和对照组进行临床对照研究。治疗组联合应用醒脑静、清开灵及脑乐欣注射液静滴 ,配合常规西药 ;对照组单纯应用常规西药。结果 治疗组治愈率 91 6 7% ,病死率为 0 ;对照组治愈率 70 83% ,病死率 10 42 %。治疗组疗效明显优于对照组 ,经统计学处理具有显著差异 (P <0 0 1)。结论 采用醒脑静、清开灵及脑乐欣联合治疗急性病毒性脑炎疗效好 ,安全可行
Objective To investigate the clinical value of combined therapy in the treatment of acute viral encephalitis. Methods The treatment group and the control group were controlled by a controlled trial. Treatment group combined with Xingnaojing, Qingkailing and cerebral Le Xin injection intravenously, with conventional Western medicine; control group simply the use of conventional Western medicine. Results The cure rate of the treatment group was 91 6 7%, the case fatality rate was 0; the cure rate of the control group was 70 83% and the mortality rate was 10 42%. The treatment group was significantly better than the control group, statistically significant difference (P <0.01). Conclusions The treatment of acute viral encephalitis with Xingjingjing, Qingkailing and Lelexin is effective, safe and feasible